It is also reported that multiple myeloma (MM) patients with higher CPNE5 expressions had longer event-free survival and overall survival, suggesting that CPNE5 might be used as a positive indicator for MM (Yang et al., 2018). This evidence concerns the gene CPNE5 and Miyoshi myopathy.